M. Stoltz
- Co-authors
- Scott J. WeirTanya L. RussellLeonard B. SaltzP. MaslakDavid P. KelsenDavid H. IlsonWilliam P. TongEileen M. O’Reilly
- Topics
- Colorectal Cancer Treatments and Studies (4 papers)Cancer Treatment and Pharmacology (4 papers)Lung Cancer Treatments and Mutations (4 papers)
- Partner nations
- United StatesGermany
In The Last Decade
M. Stoltz
17 papers receiving 604 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 236
- Oncology 234
- Pulmonary and Respiratory Medicine 138
- Hematology 68
- Cell Biology 66
Countries citing papers authored by M. Stoltz
This map shows the geographic impact of M. Stoltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Stoltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Stoltz more than expected).
Fields of papers citing papers by M. Stoltz
This network shows the impact of papers produced by M. Stoltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Stoltz. The network helps show where M. Stoltz may publish in the future.
Co-authorship network of co-authors of M. Stoltz
This figure shows the co-authorship network connecting the top 25 collaborators of M. Stoltz. A scholar is included among the top collaborators of M. Stoltz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Stoltz. M. Stoltz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 53 | |
| 7 | 5 | |
| 8 | 17 | |
| 9 | 1 | |
| 10 | 58 | |
| 11 | 129 | |
| 12 | Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. | 12 |
| 13 | 152 | |
| 14 | A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion. | 6 |
| 15 | 106 | |
| 16 | 21 | |
| 17 | 10 | |
| 18 | 23 | |
| 19 | 31 |
About M. Stoltz
M. Stoltz is a scholar working on Clinical Biochemistry, Rehabilitation and Oncology, having authored 19 papers that have together received 635 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Immunology and Allergy (52 citations), Oncology (234 citations) and Hematology (68 citations). M. Stoltz has collaborated with scholars based in United States and Germany. Frequent co-authors include Scott J. Weir, Tanya L. Russell, Leonard B. Saltz, P. Maslak, David P. Kelsen, David H. Ilson, William P. Tong, Eileen M. O’Reilly, Gary K. Schwartz and R. H. McKee. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.